Artificial intelligence (AI) continues to redefine the future of healthcare, from detecting cancer faster to improving diagnostic accuracy across hospitals. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced the second phase of its AI Airlock program, a new initiative that provides a controlled environment to test and validate AI-powered medical technologies safely […]
The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have announced the early rollout of their accelerated aligned pathway for medicines launching six months sooner than originally planned. This new approach aims to streamline regulatory and value assessment processes, allowing patients to gain faster access to […]
On October 3, 2025, the FDA launched a pilot prioritization program to speed up the review of abbreviated new drug applications (ANDAs) for companies that manufacture and test their products in the U.S. The program aims to boost domestic drug production and R&D while reducing reliance on foreign supply chains. Currently, over half of U.S. […]
The U.S. Food and Drug Administration (FDA) has authorized the marketing of Essilor Stellest eyeglass lenses, the first glasses designed to both correct nearsightedness (myopia) and slow its progression in children ages 6 to 12. This marks an important step in addressing the growing prevalence of childhood myopia, a condition which affects around 40% of […]
The US FDA has been working in collaboration with GSK towards developing treatment to manage symptoms of patients struggling with autism, thereby on 22nd of September the FDA granted approval for Wellcovorin (leucovorin calcium tablets) for patients with Cerebral folate deficiency (CFD). Cerebral folate deficiency (CFD) is a neurological disorder that impairs the transport of […]
Submit RFI/RFP
Request Consultation